Emerging Markets Will Lead World Healthcare Market Growth, With China’s Healthcare Reform Shuffling Drug Distribution: Shanghai Bio-Forum
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Developing countries will be the first and fastest to recover from the global economic downturn, and emerging healthcare markets in those countries will lead growth rates in the future, Zhu Baoquan, former president of the Shanghai Institute of Pharmaceutical Industry, said June 1 during the Bio-Forum conference in Shanghai
You may also be interested in...
China’s Essential Drug System Expected To Consolidate Generic Industry, Promote Innovative R&D
SHANGHAI - China's essential drug system will hasten the consolidation of the generic industry while a measure for drug pricing will encourage innovation, according to a Frost & Sullivan report on the impact of China's healthcare reform, released May 18
Sanofi-Aventis Sees Diversifying In China As Key To Success; Expands Capacity For Diabetes Treatment Lantus
SHANGHAI - Sanofi-Aventis announced a series of expansion plans in China aimed at diversifying its portfolio, the CEO said April 21 during his first trip to China
China Issues Three-year Healthcare Reform Plan To Invest RMB 850 Billion
SHANGHAI - China issued its long-awaited three-year plan for its healthcare reform, and unveiled how the country will allocate RMB 850 billion ($124 billion) in the next three years